Results 61 to 70 of about 507,938 (128)

Distribution of anal HPV types included (or not included) in the 9-valent Gardasil-9® vaccine.

, 2018
Number of low-risk (LR) and high-risk (HR) HPV genotypes in 29 anal swabs positive for HPV DNA by molecular biology according to their possible prevention by 9-valent HPV vaccine among study men who have sex with men (n = 42) living in the Central ...
Jean De Dieu Longo (4574164), David Veyer (5278430), Serge Police Camengo (5278421), Leman Robin (5278424), Laurent Belec (4574161), Jean-François Meye (5278433), Christian Diamant Mossoro-Kpinde (5278427), Marcel Mbeko Simaleko (4574170), Gérard Grésenguet (4574158), Hélène Péré (5278436), Mathieu Matta (5278439), Ralph-Sydney Mboumba Bouassa (4752159)   +11 more
core   +1 more source

Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada

The International Journal of Health Planning and Management, Volume 41, Issue 4, Page 572-579, July 2026.
ABSTRACT Introduction This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi‐ethnic group of youth (aged 11–23 years) in Edmonton, Alberta, Canada. Method Using a cross‐sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire.
Sarah Deck, Se Lim Jang, Rachel Harris, Fariba Kolahdooz, Moutasem Zakkar, Sangita Sharma   +5 more
wiley   +1 more source

Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.

PLoS ONE, 2020
BACKGROUND:Cervical cancer associated with high risk-human papillomavirus (HR-HPV) infection is becoming the one of the most common female cancer in many sub-Saharan African countries. First-generation immigrant African women living in Europe are at-risk
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Camélia Gubavu, Thierry Prazuck, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé, Laurent Bélec   +8 more
doaj   +1 more source

From Awareness to Action Study: Improving Human Papillomavirus Knowledge, Screening and Vaccine Uptake Among Mother‐Adolescent Pairs in the HOMINY Study in Nigeria: A Longitudinal Study

Journal of the International AIDS Society, Volume 29, Issue S2, July 2026.
ABSTRACT Introduction Persistent cervical infection with high‐risk human papillomavirus (HPV) in women is a leading cause of cervical cancer, and its co‐infection among people living with HIV increases the risk of other HPV‐associated cancers, including oropharyngeal and anogenital cancers.
Oluwaseun Peter, Elohor Oborevwori, Esosa Osagie, Paul Akhigbe, Nosakhare L. Idemudia, Ozoemene Obuekwe, Fidelis E. Eki‐Udoko, Nicholas Schlecht, Yana Bromberg, Praise O. Okoh‐Aihe, Nosayaba Osazuwa‐Peters, Modupe O. Coker, HOMINY Study Group   +12 more
wiley   +1 more source

Human Papillomavirus: Update in Bridging Basic Science to Clinical and Public Health Innovations

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Human papillomavirus (HPV), a non‐enveloped, double‐strand DNA viral pathogen, is intricately linked with the onset of various cancers, including cervical cancer and head and neck cancers. The present paper delves into HPV's ancient recognition and significant milestones such as the discovery of its role in oncogenesis and the development of ...
Fatemeh Beygnejad, Narges Eslami, Kaveh Gharaei Nejad, Atefeh Zamani Kermanshahi, Hossein Bannazadeh Baghi   +4 more
wiley   +1 more source

Modélisation numérique des aspects immunologiques de la réaction à l’infection à HPV et de la vaccination anti-HPV par Gardasil®

, 2011
Two prophylactic vaccines have demonstrated to prevent infections with the human papillomavirus (HPV). Thus, they have been in the market for the last four years, or so.
Olivera-Botello, Gustavo
core   +3 more sources

Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Oncogenic viral and bacterial infections constitute a significant portion of the global cancer burden, accounting for up to 15% of cases, particularly in low‐ and middle‐income countries. Prophylactic vaccination thus appears to be the most effective tool for preventing these preventable cancers, especially those linked to human papillomavirus
Christian Tague, Johan Domga, Ayesha Junaid, Okhesomi Rejoice Eshemokhai, Josias Kamgang Silatchom, Criss Koba Mjumbe   +5 more
wiley   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Superstitions on Human Papillomavirus in Africa: A Scoping Review

Public Health Challenges, Volume 5, Issue 2, June 2026.
Africa bears a high burden of HPV‐induced diseases; this scoping review explored how superstitions and cultural beliefs fuel vaccine hesitancy. There are widespread myths and opposition from cultural/religious leaders that drive HPV vaccine hesitancy; targeted and culturally sensitive campaigns/educations are essential to improve vaccine uptake and ...
Jimoh Amzat, Kafayat Aminu, Rita Amarachi Nwebo, Precious Nnannah, Chiamaka Norah Ezeagu, Ganiyat Amzat, Kehinde Kazeem Kanmodi   +6 more
wiley   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç«

, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質èå¹æ ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼åå競ç­çç°å¢ï¼é²èé æ業èé競ç­åå¹å½±é¿å¶å質èå©æ½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core   +1 more source